» Articles » PMID: 37189748

Autoimmunity and Carcinogenesis: Their Relationship Under the Umbrella of Autophagy

Overview
Journal Biomedicines
Date 2023 May 16
PMID 37189748
Authors
Affiliations
Soon will be listed here.
Abstract

The immune system and autophagy share a functional relationship. Both innate and adaptive immune responses involve autophagy and, depending on the disease's origin and pathophysiology, it may have a detrimental or positive role on autoimmune disorders. As a "double-edged sword" in tumors, autophagy can either facilitate or impede tumor growth. The autophagy regulatory network that influences tumor progression and treatment resistance is dependent on cell and tissue types and tumor stages. The connection between autoimmunity and carcinogenesis has not been sufficiently explored in past studies. As a crucial mechanism between the two phenomena, autophagy may play a substantial role, though the specifics remain unclear. Several autophagy modifiers have demonstrated beneficial effects in models of autoimmune disease, emphasizing their therapeutic potential as treatments for autoimmune disorders. The function of autophagy in the tumor microenvironment and immune cells is the subject of intensive study. The objective of this review is to investigate the role of autophagy in the simultaneous genesis of autoimmunity and malignancy, shedding light on both sides of the issue. We believe our work will assist in the organization of current understanding in the field and promote additional research on this urgent and crucial topic.

Citing Articles

Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression.

Dalle Carbonare L, Minoia A, Vareschi A, Piritore F, Zouari S, Gandini A Cells. 2024; 13(5.

PMID: 38474372 PMC: 10930675. DOI: 10.3390/cells13050408.


Sirtuins Affect Cancer Stem Cells via Epigenetic Regulation of Autophagy.

Sipos F, Muzes G Biomedicines. 2024; 12(2).

PMID: 38397988 PMC: 10886574. DOI: 10.3390/biomedicines12020386.


Immune Checkpoint Pathway Expression in Lymphocyte Subpopulations in Patients with Common Variable Immunodeficiency and Chronic Lymphocytic Leukemia.

Mertowska P, Mertowski S, Smolak K, Kita A, Kita G, Guz K Cancers (Basel). 2023; 15(21).

PMID: 37958359 PMC: 10649987. DOI: 10.3390/cancers15215184.

References
1.
Urbano A, Nascimento C, Soares M, Correia J, Ferreira F . Clinical Relevance of the serum CTLA-4 in Cats with Mammary Carcinoma. Sci Rep. 2020; 10(1):3822. PMC: 7052166. DOI: 10.1038/s41598-020-60860-3. View

2.
Rhee I . Diverse macrophages polarization in tumor microenvironment. Arch Pharm Res. 2016; 39(11):1588-1596. DOI: 10.1007/s12272-016-0820-y. View

3.
Duan Z, Shi Y, Lin Q, Hamai A, Mehrpour M, Gong C . Autophagy-Associated Immunogenic Modulation and Its Applications in Cancer Therapy. Cells. 2022; 11(15). PMC: 9367255. DOI: 10.3390/cells11152324. View

4.
Zhong Z, Umemura A, Sanchez-Lopez E, Liang S, Shalapour S, Wong J . NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell. 2016; 164(5):896-910. PMC: 4769378. DOI: 10.1016/j.cell.2015.12.057. View

5.
Colli M, Hill J, Marroqui L, Chaffey J, Dos Santos R, Leete P . PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction. EBioMedicine. 2018; 36:367-375. PMC: 6197434. DOI: 10.1016/j.ebiom.2018.09.040. View